Pharma Journalist -

Therapix Biosciences announced that it has entered into an exclusive agreement with Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and…
Read More...

Immatics announced the completion of its Series E financing, raising $58 million. The Series E funding was supported by existing investors including dievini Hopp Biotech holding,…
Read More...

Transgene and Randox have entered into a collaboration to combine their technologies and develop multifunctional oncolytic immunotherapies. Innovative oncolytic viruses (OVs) resulting…
Read More...

The Alzheimer's Drug Discovery Foundation (ADDF) and Pfizer's Centers for Therapeutic Innovation (CTI) announced they will jointly support a new project that could result in a potential…
Read More...

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for ALUNBRIG® (brigatinib) 180…
Read More...

MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and…
Read More...

Lonza announced that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc. Financial details of the deal were not disclosed. The…
Read More...

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Dimension Therapeutics, Inc. announced…
Read More...

Aytu BioScience, Inc., a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced that the company has entered into a…
Read More...

Gilead Sciences, Inc. announced a new licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed public health organization, to expand access to bictegravir (BIC)…
Read More...